| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.32B | 1.37B | 1.31B | 1.04B | 766.79M |
| Gross Profit | 284.95M | 349.61M | 336.22M | 295.31M | 264.19M |
| EBITDA | 34.02M | 128.54M | 175.06M | 120.16M | 135.63M |
| Net Income | -63.01M | 54.39M | 77.90M | 68.72M | 86.19M |
Balance Sheet | |||||
| Total Assets | 1.61B | 1.73B | 1.65B | 1.63B | 1.17B |
| Cash, Cash Equivalents and Short-Term Investments | 241.87M | 357.26M | 381.38M | 364.24M | 392.74M |
| Total Debt | 126.02M | 100.70M | 69.99M | 16.09M | 6.54M |
| Total Liabilities | 1.00B | 958.44M | 875.17M | 921.79M | 586.22M |
| Stockholders Equity | 575.69M | 693.09M | 696.95M | 614.66M | 523.79M |
Cash Flow | |||||
| Free Cash Flow | -5.68M | -19.66M | 72.43M | -29.97M | 201.68M |
| Operating Cash Flow | 5.09M | -10.73M | 79.30M | -23.07M | 207.20M |
| Investing Cash Flow | -12.02M | -77.89M | 13.80M | -91.79M | -222.53M |
| Financing Cash Flow | -27.57M | -15.71M | 4.79M | -22.61M | 116.04M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$829.17M | ― | 6.41% | 8.44% | 14.21% | -7.54% | |
70 Outperform | HK$210.53M | 1.77 | 15.16% | 11.22% | 4.17% | 10.89% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
54 Neutral | HK$199.72M | 5.50 | 4.27% | 6.60% | -9.97% | -46.38% | |
52 Neutral | HK$2.91B | 30.35 | 10.94% | ― | 7.77% | -7.65% | |
42 Neutral | HK$205.61M | -1.05 | 4.36% | ― | -5.08% | -682.55% | |
41 Neutral | HK$392.00M | -1.43 | 2.68% | ― | -0.62% | -220.23% |